Kidswell Bio Corporation Email Formats

Biotechnology Research • 新川一丁目2番12号, 中央区, Japan • 11-20 Employees

Kidswell Bio Corporation Email Formats

Kidswell Bio Corporation uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@kidswellbio.com), used 70% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@kidswellbio.com	70%
{first initial}.{last name}	j.doe@kidswellbio.com	30%

Key Contacts at Kidswell Bio Corporation

Nao Oosuga

Chief Director, Corporate Strategy Division

Hiroshi Kohara

Director

Yasuyuki Mitani

Member Board Of Directors

Keisuke Hamada

Deputy Director, Manufacturing Development Dept. Manufacturing Div.

Company overview

Headquarters	新川一丁目2番12号, 中央区, 東京都 104-0033, JP
Website	kidswellbio.com
NAICS	541714
Keywords	再生医療, バイオシミラー, バイオ新薬, 創薬, 細胞治療, バイオテック
Founded	2001
Employees	11-20

About Kidswell Bio Corporation

Kidswell Bio Corporation (KWB), formerly known as Gene Techno Science, has been growing by leveraging our expertise in Biosimilar field in Japan. By 2024, four BS products were brought to market by our partner pharmaceutical companies as outcomes of co-developments between the companies and KWB. Besides, KWB has engaged in research and development for regenerative medicine with stem cells from human exfoliated deciduous teeth (SHED) since 2019, which targeted pediatric diseases, orphan disease and intractable disease with the aim of achieving comprehensive healthcare solutions for patients suffering from these diseases as well as for their families and caregivers. On the 1st of April 2024, the regenerative medicine business became independent as S-Quatre Corporation (SQ). KWB and SQ lead biosimilar business and regenerative medicine businessrespectively, and grow together as two pillars of Kidswell Bio group. キッズウェル・バイオ株式会社(旧株式会社ジーンテクノサイエンス)はバイオシミラー医薬品事業により成長してきた。パートナー製薬企業との共同開発の結果、2024年までに4つのバイオシミラー製品を日本にて上市させている。一方で、2019年からは、乳歯由来歯髄幹細胞を用いた再生医療の研究開発に着手し、希少疾患、難病に加えて、小児疾患を重点的なターゲットと定め、患者様、及びそのご家族や介護者の方を含めた包括的なケアを目指した研究開発を行なってきた。KWBは2024年4月1日にこの再生医療事業を専門に行なう子会社である株式会社S-Quatreを設立し、現在はキッズウェル・バイオグループとしてバイオシミラーと再生医療の両事業を展開している。

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

Entry

Senior

Employees by Department

Kidswell Bio Corporation has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Kidswell Bio Corporation's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2013-03-28	14	$13,200,000

Funding Insights

$13,200,000

Total funding amount

$13,200,000

Most recent funding amount

Number of funding rounds

Kidswell Bio Corporation Tech Stack

Discover the technologies and tools that power Kidswell Bio Corporation's digital infrastructure, from frameworks to analytics platforms.

DNN

CMS

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Google Analytics

Analytics

Microsoft ASP.NET

Web frameworks

jQuery UI

JavaScript libraries

Frequently asked questions

Kidswell Bio Corporation is located in 新川一丁目2番12号, 中央区, JP.

Kidswell Bio Corporation was founded in 2001, making it 25 years old. The company has established itself as a significant player in its industry over this time.

Kidswell Bio Corporation has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Kidswell Bio Corporation has raised a total of $13,200,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Kidswell Bio Corporation

Nao Oosuga

Chief Director, Corporate Strategy Division

Hiroshi Kohara

Director

Yasuyuki Mitani

Member Board Of Directors

Keisuke Hamada

Deputy Director, Manufacturing Development Dept. Manufacturing Div.

4.8

40,000 users